85% of Virginia children needing allogeneic transplants travel outside the state to receive them. UVA Children's completed an important milestone toward meeting this need.
Author: Megan Davis (Page 5)
Our discovery shocked the medical community. Now we're finding answers to the most devastating neurological disorders.
How one of only a few multidisciplinary treatment programs for SMA in Virginia cares for children throughout the region.
One of only 15 healthcare centers in the country with the expertise to treat FMD effectively, UVA Health Heart & Vascular is contributing to research efforts that could lead to new therapies for this complex and serious disease.
UVA Health is among the few high-volume cardiac care centers in the country with the requisite skills and dedicated expertise to tackle chronic total occlusion. Find out how we achieve high success rates and life-changing outcomes.
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Discover the new worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.
Serving as a quaternary referral center, we give patients access to innovative procedures and devices only available at select centers.
Hypertrophic cardiomyopathy has historically been less well-understood than other cardiac conditions, but research at UVA Health is opening the door to tailored interventions.